IL10 agonists and methods of use thereof
US12187772B2 · kind B2 · utility
0Cited by
10References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 28, 2023 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Apr 28, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to IL10 agonists with improved anti-tumor therapeutic efficacy and uses thereof. Certain IL10 agonists disclosed herein comprise an IgG Fc domain, a linker moiety, and an IL10 moiety.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.